AI-assisted Gastric Cancer Diagnosis System

About it

The Gastric Biopsy AI-Assisted Diagnostic System is designed for automatic detection and classification of gastric cancer and precancerous lesions.
It addresses key challenges in pathology such as slow lesion localization and difficulty in tumor subtype identification.
By significantly reducing analysis time and supporting structured report generation, it enhances diagnostic accuracy and efficiency while providing standardized data for research.

Multi-Lineage Recognition

Covers gastric carcinoma (adenocarcinoma, mucinous, signet-ring cell), precancerous lesions, and benign conditions.

 Precise Tumor Segmentation

Automatically delineates tumor boundaries to assist lesion extent assessment.

High Clinical Consistency

96%+ agreement with pathologists from top hospitals; validated on 50,000+ multi-center slides.

 Comprehensive Data Foundation

Trained on 50,000+ slides from 10 hospitals covering diverse gastric sites.

Seamless Report Integration

Generates structured reports with tumor subtype, grade, and heatmap visualization.

Optimized Workflow

Reduces pathologists’ workload and shortens report generation time by up to 80%.

Recognizable Lesion Types
Primary Category Secondary Attribute
Positive Signet Ring Cell Carcinoma
Adenocarcinoma
High-grade Intraepithelial Neoplasia
Low-grade Intraepithelial Neoplasia
Positive Mild / Moderate / Severe
Negative Active Inflammation
Chronic Inflammation Mild / Moderate / Severe
Intestinal Metaplasia
Atrophy
Hemorrhage

Powering global digital pathology with performance, scale, and trust

The Numbers Behind Our Innovation

0% +
Detection rate of gastric cancer (G4+)
0%
Detection rate of advanced precancerous lesions (G3+)
0%
Negative predictive value (NPV)

Network and GPU Server Requirements